论文部分内容阅读
目的:评价化疗加放射治疗中晚期鼻咽癌的临床效果。方法:对84例临床Ⅲ～Ⅳ期的鼻咽癌患者分别实施单纯放射治疗(单放)组33例和化疗加放射治疗(化放)组51例行临床观察治疗前后的肿瘤大小,比较其近期的临床疗效(CR+PR)及5年生存率。结果:单放组、化放组有效率(CR+PR)分别为81.2%(17/33)、90.1%(46/51),P<0.01,5年生存率分别为42.4%(14/33)、66.6%(34/51),P<0.01。结论:化疗加放射治疗中晚期鼻咽癌可望提高临床疗效及延长患者的生存期。
Objective: To evaluate the clinical effect of chemotherapy plus radiation therapy on advanced nasopharyngeal carcinoma. Methods: Totally 84 patients with stage Ⅲ ~ Ⅳ nasopharyngeal carcinoma were treated with radiotherapy alone (radiotherapy alone group, 33 patients) and chemotherapy plus radiotherapy (radiotherapy (radiotherapy) group, 51 patients were observed before and after treatment of tumor size, The recent clinical efficacy (CR + PR) and 5-year survival rate. Results The effective rates of CR + PR were 81.2% (17/33) and 90.1% (46/51), respectively, P <0.01. The 5-year survival rates were 42.4% (14/33) ), 66.6% (34/51), P <0.01. Conclusion: Chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma is expected to improve the clinical efficacy and prolong the survival of patients.